Philippe Motté
Founder at Celestial Consulting & Coaching
Profile
Philippe Motté is the founder of Celestial Consulting & Coaching, which was founded in 2018.
He currently holds the title of President at Celestial Consulting & Coaching.
Mr. Motté is also currently a Member at Académie nationale de Pharmacie.
In his former positions, Mr. Motté served as the Chief Regulatory & Quality Officer at Genfit SA from 2021 to 2022, and as the Chief Access Officer at MedDay Pharmaceuticals SAS from 2019 to 2020.
He also held the position of Senior Vice President-Regulatory & Quality at Gensight Biologics SA. Mr. Motté obtained an MBA from ESCP Europe Campus London and holds doctorate degrees from Universite Paris Cite and Université Paris-Saclay.
Philippe Motté active positions
| Companies | Position | Start |
|---|---|---|
| Celestial Consulting & Coaching | Founder | 2018-05-31 |
| Académie nationale de Pharmacie | Corporate Officer/Principal | - |
Former positions of Philippe Motté
| Companies | Position | End |
|---|---|---|
| GENFIT | General Counsel | 2022-07-31 |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Corporate Officer/Principal | 2020-05-31 |
| GENSIGHT BIOLOGICS S.A. | General Counsel | - |
Training of Philippe Motté
| ESCP Europe Campus London | Masters Business Admin |
| Universite Paris Cite | Doctorate Degree |
| Université Paris-Saclay | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GENFIT | Health Technology |
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Private companies | 3 |
|---|---|
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Health Technology |
| Académie nationale de Pharmacie | |
| Celestial Consulting & Coaching |
- Stock Market
- Insiders
- Philippe Motté